DAFNA Capital Management »

Corbus Pharmaceuticals Hldgs shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 108k 9.38

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
BlackRock
Standard Life Aberdeen
Diadema Partners
Vanguard Capital Management
Jones Hill Capital
Prosight Management
Caption Management
Susquehanna International
ADAR1 Capital Management
Stonepine Capital Management
Geode Capital Management
Citadel Advisors
Dimensional Fund Advisors

View all funds holding Corbus Pharmaceuticals Hldgs